Related Experiment Video

Updated: Jun 6, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

Aetiological differences in demographical, clinical and pathological characteristics of hepatocellular carcinoma in

Nsikak J Umoh1, Olufunmilayo A Lesi, Maimuna Mendy

  • 1Department of Surgery, Geisinger Medical Center, Danville, PA 17822, USA. nsykumoh@yahoo.com

Liver International : Official Journal of the International Association for the Study of the Liver
|December 15, 2010
PubMed

Insights

Hepatocellular carcinoma (HCC) in West Africa presents at advanced stages, regardless of cause like hepatitis B or C. Few differences were found between etiological agents, highlighting the need for early detection strategies.

Area of Science:

  • Hepatology
  • Oncology
  • Infectious Diseases

Background:

  • Hepatocellular carcinoma (HCC) is a prevalent malignancy globally, with a significant burden in West Africa.
  • Limited data exist on etiological differences in HCC presentation within this region.

Purpose of the Study:

  • To characterize the demographical, clinical, and pathological features of HCC based on etiological factors.
  • To investigate associations between hepatitis B virus (HBV), hepatitis C virus (HCV), and aflatoxin exposure in HCC patients.

Main Methods:

  • Analysis of 193 HCC cases diagnosed in The Gambia between 1997 and 2001.
  • Comparison of patient characteristics by etiology using appropriate statistical tests (chi-squared, t-tests, Wilcoxon rank-sum).

Main Results:

  • Prevalence of HBV surface antigen, HCV antibody, and aflatoxin-associated TP53 mutations were 60%, 20%, and 38%, respectively.
  • Typical patient: 49-year-old male with HBV, presenting with hepatomegaly, abdominal pain, and weight loss.
  • Most patients had multifocal lesions, background cirrhosis, advanced stage HCC (84%), median largest tumor 10.3 cm, and median AFP 500 ng/ml.

Conclusions:

  • HCC in West African populations presents at advanced stages, irrespective of the etiological agent.
  • Minimal clinical or pathological distinctions were observed among different etiologies.
  • Further research is required to understand hepatocarcinogenesis mechanisms and identify high-risk groups for screening.
Abstract

More Related Videos

Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice10:35

Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice

Published on: September 25, 2013

Related Concept Videos

Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...